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cense.Abstract Four methods have been developed for the simultaneous determination of phenylephrine
hydrochloride and chlorpheniramine maleate without previous separation. In the ﬁrst method both
drugs are determined using ﬁrst derivative UV spectrophotometry, with zero-crossing measurement.
The second method depends on ﬁrst derivative of the ratios spectra. The third method describes the
use of multivariate spectrophotometric calibration for the simultaneous determination of the ana-
lyzed binary mixture where the resolution is accomplished by using partial least squares (PLS)
regression analysis. In the fourth method (HPLC), a reversed-phase column and a mobile phase
of methanol:water:acetonitrile (80:12:8 v/v/v/) at 0.9 ml/min ﬂow rate have been used to separate
both drugs with a UV detection at 270 nm. All the proposed methods are extensively validated.
They have the advantage to be economic and time saving. All the described methods can be readily
utilized for analysis of pharmaceutical formulations. The results obtained using the proposed meth-
ods are statistically analyzed and compared with some reported methods.
ª 2010 King Saud University. Open access under CC BY-NC-ND license.om
ity.
lsevier1. Introduction
Phenylephrine hydrochloride is a sympathomimetic drug. It
can be used as a nasal decongestant (El-Hawary et al., 1985).
The most recent methods for determination of phenylephrine
hydrochloride included chromatographic (Chien and Schoen-
wold, 1985; Wilson et al., 1985; Al-Kaysi and Salem, 1986;
Lioyd et al., 1987), electrochemical (Kuz and Kramarenko,
1984; Lucy and Cantwell, 1986) and spectrophotometric
(Mayers and Tayler, 1987; Baker and Lowe, 1985; Besada,
1987; Ahmed and Amin, 2007; Korany et al., 1985; Li and
Lubman, 1988) techniques.
16 N.H. Al-ShaalanChlorpheniramine maleate is anti-histaminic drug (El-Haw-
ary et al., 1985). Several methods have been reported for chlor-
pheniramine maleate assay including chromatographic (Seki
et al., 1988; Lavagine and Zee, 1987; Lioyd and Whit, 1988)
and spectrophotometric (Louhaichi et al., 2009; Fasanmda
et al., 1985; Kitamura and Majma, 1983) techniques.
Recently, derivative spectrophotometry has been found to
be a useful method in the determination of mixtures with
two or more components having overlapping spectra and in
eliminating interference from formulation matrix by using
the zero-crossing techniques (Salem, 1999, 2006; Mabrouk
et al., 2003).
Furthermore, ratio-spectra derivative spectrophotometric
method has also been found to be useful in the estimation of
drugs in their mixtures (Moor et al., 2002; Kenney et al.,
2000; Shamsipur and Jalali, 2000; Cheng and Peng, 1998;
Mushik et al., 1998). Such a method permits the determination
of a component in their mixture at the wavelengths corre-
sponding to a maximum or minimum and also the use of
the peak-to-peak between consecutive maximum and mini-
mum. The main advantage of derivative of the ratio-spectra
method may be the chance of easy measurements in corre-
spondence of peaks so it permits the use of the wavelength
of highest value of analytical signals (maximum or minimum).
Moreover, the presence of a lot of maxima and minima is an-
other advantage by the fact that these wavelengths give an
opportunity for the determination of active compounds in
the presence of other active compounds and excipients which
possibly interfere in the analysis.
Multivariate calibration methods applied to spectral data
are being increasingly used for pharmaceutical analysis. Clas-
sical least squares (CLS) and principal components regression
(PCR) analysis are the most simplest multivariate methods
that can be performed with easily accessible statistical software
(Mohamed et al., 2005; Abde El-Maaboud and Pakinaz, 2002;
Jose Aurelia and Pablo, 2001; Hector and Alejandro, 1998).
CLS technique assumes that responses (absorbance) at
each frequency (wavelengths) are proportional to component
concentration units. Model errors are assumed to derive from
the measurement of spectral absorbance. So CLS requires
that all interfering chemical components be known and
included in the calibration data set. CLS has the advantage
of improved precision when using many frequencies, due to
signal averaging.
Calibration is realized by recording the spectra at n-wave-
lengths of m standard mixtures, of known composition of c
components. The spectra (absorbance or emission) are ar-
ranged into the columns of matrix Y (dimensions n · m), with
the composition of each mixture forming the columns of con-
centration matrix X (c · m)
Y ¼ K  X ð1Þ
With a prior knowledge of X and by recording data for Y, then
the matrix of sensitivities, K, can be calculated, but after the
rearrangement of Eq. (1) to the following equation by multi-
plying the equation components by Xt value as:
Y  Xt ¼ K  X  Xt
K ¼ ðX  XtÞ1  Y  Xt ð2Þ
To avoid being under-determined, there must be measure-
ments at more wavelengths than there are components (i.e.nP c). If n> c then the component concentrations in an un-
known mixture are obtained from its spectrum by,
Xunknown ¼ ðKt  KÞ1  Ktyunknown ð3Þ
This CLS method is intuitively appealing since it is based on
some generally assumed relationship, e.g. Beer’s law, and it
can be used for moderately complex composition of the cali-
bration mixtures, i.e. the concentration of each absorbing spe-
cies. PCR is a two-step procedure, in the ﬁrst step, one
estimating the number of principal components by one or
more of the following criteria, the percentage of explained
variance, eigen value-one criterion, the Scree-test and Cross
validation. They can be considered as new variables that
summarize in an optimal way the variation present in the spec-
tra, in the second step, CLS is applied to the newly obtained
latent variables. When co-linearity between original variables
occurs, principal component plots often allow better interpre-
tation of the variations observed in the data set than plots of
original variables selected by CLS. As modeling method, it is
less performant than CLS when performing prediction within
the calibration domain and when the model is indeed linear.
It is more reliable if extrapolation may be required. It is a lin-
ear method, but it is able to perform quite well for moderately
nonlinear data. As CLS, it is a global method (Beebe and
Kowalski, 1987; Wetzel, 1983; Hernandez-Arteseros et al.,
2000; Adam, 2004).
HPLC methods are useful in the determination of drugs in
pharmaceutical dosage forms and biological sample. Owing to
the widespread use of HPLC in routine analysis, it is important
that good HPLC methods are developed and that these are
thoroughly validated (Pesez and Bartos, 1974; Moffat et al.,
1986; Fijalek et al., 1992).
The purpose of the present study was to investigate the
utility of derivative, derivative ratio spectrophotometry,
multivariate and HPLC techniques in the assay of phenyl-
ephrine hydrochloride and chlorpheniramine maleate in
pharmaceutical preparations without the necessity of sample
pre-treatment.2. Experimental
2.1. Apparatus and conditions
The Hewlett–Packard liquid chromatographic system con-
sisted of a gradient Quat pump Model G 1311 A (HP, Avon-
dale, PA, USA) connected with an HP G 1314 A UV–VIS
detector (HP, Avondale, PA, USA) operating at 265 nm, a G
1328 A (Cotati, CA) injection valve, with a 20 ll loop. The
chromatographic data were collected and analyzed using HP
Chem Station for LC and LC/MS system (Hewlett–Packard,
Avondale, PA, USA). The chromatographic separation was
performed at ambient temperature (20–22 C) using an analyt-
ical column, Spherisorb, 5 lm, 4.6 · 150 mm i.d. (Waters,
Milford, MA, USA). The reversed mobile phase was obtained
by mixing methanol:water:acetonitrile (70:22:8 (v/v/v)). The
ﬂow rate was 0.9 ml/min. Finasteride was used as an internal
standard.
Spectrophotometric measurements were carried out on a
computerized Spectronic Gensys 2PC, UV/Vis Spectropho-
tometer (Milton Roy, USA), using 1.00 cm quartz cells. The
obtained spectral data were saved in PC apparatus program
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transferring the spectral data to Microsoft excel XP program
and processing them with the standard curve ﬁt package and
matrix calculations. Sonicator (Bransonic 220/Bender-Hobein),
Heater (Salvis) (Heidolph).
Balance (Mettler Toledo). Curve Expert version 1.37 Copy-
rightª 1995–2001 by Daniel Hyams. GraphPad Instat version
3.05, 32 bit for win 95/NT created September 27, 2000 Copy-
rightª 1992–2000 by GraphPad software.
2.2. Chemicals, reagents and pharmaceutical preparations
All chemicals were of analytical-reagent grade and solvents
were of spectrophotometric and HPLC grade. Phenylephrine
hydrochloride and chlorpheniramine maleate were kindly pro-
vided by the Pharco Co., Egypt, ﬁnasteride used, as internal
standard was supplied from Aldrich. HPLC grade methanol
(Merk, Darmstadt, Germany) and doubly distilled water was
used for preparing mobile phase solutions. For spectrophoto-
metric studies, methanol was purchased from Merk (Darm-
stafd, Germany). Sine Up syrup (Pharco Co., Egypt) labeled
to contain 100 mg% phenylephrine hydrochloride and 50%
chlorpheniramine maleate.
2.3. Preparation of standard solutions and calibration
Stock standard solutions containing 1.0 and 0.5 mg phenyleph-
rine hydrochloride and chlorpheniramine maleate, respec-
tively, were dissolved in 10 ml methanol. Standard solutions
of both drugs were prepared individually by dilution of the
stock solutions with methanol for spectrophotometric methods
to obtain concentration range of 10–100 lg/ml for phenyleph-
rine hydrochloride and 5–60 lg/ml for chlorpheniramine male-
ate and in mobile phase preparation for chromatographic
method to reach concentration range of 0.10–10 and 0.05–
5 lg/ml for phenylephrine hydrochloride and chlorphenir-
amine maleate, respectively.
2.4. For derivative spectrophotometric method (D1)
The values of the D1 amplitudes were measured at 270 nm
(zero-crossing of phenylephrine hydrochloride) and 280 nm
(zero-crossing of chlorpheniramine maleate) for the determina-
tion of chlorpheniramine maleate and phenylephrine hydro-
chloride, respectively.
2.5. For ﬁrst derivative of the ratio spectrophotometric method
(DD1)
According to the theory of the ratio-spectra derivative method
(Beebe and Kowalski, 1987; Fijalek et al., 1992). The stored
UV absorption spectra of the standard solutions of phenyleph-
rine hydrochloride were dividedwavelength-by-wavelength by a
standard spectrumof chlorpheniraminemaleate (15 lg/ml). The
ﬁrst derivative was calculated for the obtained spectra with
Dk= 3 nm. The amplitudes at 280.2 nm was measured and
found to be linear to the concentration of chlorpheniramine.
For phenylephrine hydrochloride, the stored UV absorp-
tion spectra of standard solutions of felodipine were divided
wavelength-by-wavelength by a standard spectrum of meto-
prolol (20 lg/ml). The ﬁrst derivative was calculated for theobtained spectra with Dk= 3 nm. The amplitudes at 294.8 nm
was measured and found to be linear to the concentration of
phenylephrine hydrochloride.
2.6. For multivariate method
In order to obtain the calibration matrix for applying CLS and
PCR analysis, 10 solutions of each of the pure components
(phenylephrine hydrochloride and chlorpheniramine maleate)
were prepared with concentrations in the range 10–60 and
4–30 lg/ml for phenylephrine hydrochloride and chlorphenir-
amine maleate, respectively. These ranges were previously ver-
iﬁed to obey Beer’s law for each of the studied drugs in the
selected solvent. The absorption data in the range of 100–
400 nm (digitized every 3.0 nm) were subjected to least squares
analysis in order to obtain the calibration K matrix. Labora-
tory prepared mixtures were prepared by mixing known
amounts of phenylephrine hydrochloride and chlorphenir-
amine maleate in different varied proportions in order to verify
the precision of the method for analysis of such mixture and
matching the commercial tablets with those having compara-
ble concentrations.
2.7. For high-performance liquid chromatographic method
Standard solutions were prepared separately with mobile
phase by varying concentrations of phenylephrine hydrochlo-
ride and chlorpheniramine maleate in the range 0.50–20 and
0.25–10 lg/ml, respectively. Maintaining concentration of ﬁn-
asteride (IS) at a constant level of 3 lg/ml. Triplicate 10 ll
injections were made for each concentration and peak area ra-
tio of each concentration to the internal standard was plotted
against the corresponding concentration to obtain the calibra-
tion graph.
2.8. Accuracy study
To study the accuracy of the proposed methods, and to check
the interference from excipients present in the dosage form,
recovery experiments were carried out by the standard addi-
tion method. The study was performed by addition of different
amounts of phenylephrine hydrochloride and chlorphenir-
amine maleate to a known concentration of the pharmaceuti-
cal dosage forms. The resulting mixtures were analyzed as
described under Section 2.3.
3. Results and discussion
3.1. D1 method
As shown in Fig. 1, the UV spectra of standard drugs were
found to be overlapped making their simultaneous determina-
tion difﬁcult. In contrast, the D1 spectrum of each pure drug
was found to show zero-crossing points (Fig. 2) and assisted
in their simultaneous estimation. In practice, the wavelength
selected is that which exhibits the best linear response, giving
a zero or near zero intercept on the coordinate of the calibra-
tion graph, and not affected by the presence of any other com-
ponent. The shape of the ﬁrst derivative spectra is adequate for
determining phenylephrine hydrochloride in the presence of
chlorpheniramine maleate and vice versa.
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Figure 3 Ratio spectra of phenylephrine hydrochloride, divisor
is chlorpheniramine maleate.
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Figure 4 Ratio spectra of chlorpheniramine maleate, divisor is
phenylephrine hydrochloride.
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Figure 1 U.V. absorption of phenylephrine hydrochloride (—)
and chlorpheniramine maleate (ÆÆÆÆÆÆÆÆÆÆ).
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Figure 2 First derivative absorption of phenylephrine hydro-
chloride (—) and chlorpheniramine maleate (ÆÆÆÆÆÆÆÆÆÆÆ).
18 N.H. Al-ShaalanPhenylephrine hydrochloride was determined by measuring
of its D1 amplitude at the zero-crossing point of chlorphenir-
amine maleate (at 280 nm). While chlorpheniramine maleate
was determined by measuring of its D1 at the zero-crossing
point of phenylephrine hydrochloride (at 270 nm). Linear rela-
tionships between derivative amplitude and drug concentra-
tion were obtained over the concentration range 10–100 lg/
ml for phenylephrine hydrochloride and 5–100 lg/ml for
chlorpheniramine maleate. The linear regression equations to-
gether with correlation coefﬁcients slope and intercept, R.S.D.
of slope and intercept repeatability (within-day) and reproduc-
ibility (between-day) obtained for each drug are collected in
Table 1.Table 1 Statistical data for the calibration graphs of phenylephrine
PCR and HPLC methods.
Phenylephrine hydrochloride
D1 DD1 CLS PCR
Linearity range (lg/ml) 20–150 20–150 10–70 5–35
Slope 0.0132 0.0084 0.9866 0.750
Intercept 0.008 0.005 0.001 0.014
Correlation coeﬃcient 0.9998 0.9997 1.0000 0.999
R.S.D. of the slope 0.57 0.65 0.65 0.49
R.S.D. of the intercept 0.09 0.07 0.08 0.15
LOD (lg/ml) 5.44 5.70 4.75 5.79
LOD (lg/ml) 15.34 12.65 13.05 15.86
Repeatability (R.S.D.; %) 0.94 0.45 0.94 0.84
Reproducibility (R.S.D.; %) 0.99 0.59 0.59 0.933.2. DD1 method
The inﬂuence of Dk for obtaining the ﬁrst derivative of the ra-
tio spectra as well as, the effect of divisor concentration on the
calibration graphs for the proposed mixture was studied in or-
der to select the best factors affecting the determination. Re-
sults indicated that Dk= 4 nm was most suitable one, while
the divisor concentration has no signiﬁcant effect on the assay
results for the studied mixtures.
For determination of phenylephrine hydrochloride, the
absorption spectra of phenylephrine hydrochloride were di-
vided by that of standard solutions of chlorpheniramine male-
ate (20 lg/ml) and the absorption spectra of chlorpheniramine
maleate were divided by that of standard solutions of phenyl-
ephrine hydrochloride (8 lg/ml), Figs. 3 and 4, respectively.
The ﬁrst derivative of the developed ratio spectra were cal-
culated with Dk= 4 nm. Figs. 5 and 6 show that, phenyleph-hydrochloride and chlorpheniramine maleate by D1, DD1, CLS,
Chlorpheniramine maleate
HPLC D1 DD1 CLS PCR HPLC
0.15–15 10–60 10–60 2–10 1–6 0.03–5
6 0.2179 0.0065 0.0065 0.8433 0.8438 0.1959
0.001 0.022 0.009 0.003 0.019 0.002
9 0.9999 0.9997 0.9999 0.9999 0.9999 0.9999
0.75 0.45 0.77 0.64 0.76 0.66
0.07 0.12 0.42 0.32 0.23 0.19
3.75 9.72 3.43 6.44 8.64 2.50
10.08 40.64 7.54 19.54 24.90 4.32
0.59 0.43 0.84 0.69 0.59 0.69
0.89 0.85 0.89 0.85 0.85 0.57
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Figure 6 First derivative ratio spectra of chlorpheniramine
maleate, divisor is phenylephrine hydrochloride.
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Figure 5 First derivative ratio spectra of phenylephrine hydro-
chloride, divisor is chlorpheniramine maleate.
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tude at many wavelengths where chlorpheniramine maleate
has no contribution, but it was found that the amplitude at
294.8 nm give the most accurate and sensitive results
(Fig. 5). Fig. 6, shows that chlorpheniramine maleate can be
determined by measuring the amplitude at many wavelengths
where phenylephrine hydrochloride have no contribution,
but it was found that the amplitude at 280.2 nm give the most
accurate and sensitive results.
The proposed method is applicable over the ranges 10-
100 lg/ml for phenylephrine hydrochloride and 10–60 lg/ml
for chlorpheniramine maleate. The characteristic parameters
and necessary statistical data of the regression equations,
LOD and LOQ values, respectively and reproducibility data
are shown in Table 1.
Repeatability and reproducibility variables were character-
ized by R.S.D. (%) and by the difference between theoretical
and measured concentrations. There was no signiﬁcant differ-
ence for the assay, which was tested within-day (repeatability)
and between-days (reproducibility).
In order to demonstrate the validity and applicability of the
proposed DD1 method, recovery studies were performed by
analyzing laboratory prepared mixtures of phenylephrine
hydrochloride and chlorpheniramine maleate with different
composition ratio (Table 1).
3.3. Multivariate method
The absorption spectra of the studied drugs are shown in
Fig. 1. As could be seen, a considerable degree of spectral over-lapping occurs in the region from 200 to 300 nm for phenyl-
ephrine hydrochloride and chlorpheniramine maleate. The
degree of spectral overlapping was given by (Di)
0.5. In case
of the presently studied compounds, the spectra lead to
Di= 0.50 implying a 86.39%.
Several laboratory prepared mixtures were subjected to the
CLS and PCR analysis in order to conﬁrm the suitability of
the calibration model for determination of the studied drugs
in the pharmaceutical sample solutions. The results of com-
mercial dosage form and laboratory prepared mixtures
analysis with comparable concentrations were found closely
matched. This indicated that, excipients and additives did
not interfere with the determinations. Moreover, the results
of dosage form analysis were compared with those obtained
by applying reported method. As shown in Table 1, the results
are in good agreement with those of the reported procedure as
indicated by the calculated t and F values.
3.4. High-performance liquid chromatographic method
Drug concentration is monitored during various phases of
pharmaceutical development, such as formulation and stability
studies, quality control and pharmacological testing in animals
and humans. All these investigations require reliable and vali-
dated analytical methods in order to measure drugs in pharma-
ceutical formulations.
In order to effect the simultaneous elution of phenylephrine
hydrochloride and chlorpheniramine maleate peaks under gra-
dient conditions, the mixtures of methanol, acetonitrile and
water in different combinations at various ﬂow rates were as-
sayed. The optimum wavelength for detection was 280 nm at
which much better detector responses for both drugs were ob-
tained. The mixture of methanol: acetonitrile: water (78:12:10
(v/v/v)) at 0.9 ml/min ﬂow rate, proved to be better than the
other mixtures and ﬂow rates for separation, since the chro-
matographic peaks were better deﬁned, resolved and free from
tailing. The retention times were 2.06 min for phenylephrine
hydrochloride, 3.36 min for chlorpheniramine maleate and
4.32 min for ﬁnasteride (IS).
Finasteride was chosen as the internal standard because it
showed a shorter retention time with better peak shapes and
better resolution, compared to other potential internal
standards.
Resolution and selectivity factors for this system were
found 2.78 and 2.40 for phenylephrine hydrochloride and
chlorpheniramine maleate, respectively. Tailing and capacity
factors were obtained as 0.95 and 1.28 for phenylephrine
hydrochloride and 1.51 and 1.55 for chlorpheniramine male-
ate. The variation in retention times among six replicate injec-
tions of phenylephrine hydrochloride and chlorpheniramine
maleate standard solutions was very low, rendering an R.S.D
of 0.85% and 0.69%, respectively. The results obtained
from system suitability tests are in agreement with the USP
requirements.
Peak area ratios (A sample/AIS) were plotted against
corresponding concentrations in the range of 0.10–12 for phen-
ylephrine hydrochloride and 0.04–10 lg/ml for chlorphenir-
amine maleate. Linear regression parameters of the peak
area ratios versus concentrations of phenylephrine hydrochlo-
ride and chlorpheniramine maleate are presented in Table 1.
The results showed highly reproducible calibration curves
with correlation coefﬁcients >0.999. Statistical data of the
Table 2 Determination of phenylephrine hydrochloride and chlorpheniramine maleate in authentic, laboratory prepared mixtures
and pharmaceutical dosage form using D1, DD1, CLS, PCR, HPLC and reported methods.
Standard solution Reported D1 DD1 CLS PCR HPLC
Authentic phenylephrine 99.7 ± 0.37 99.8 ± 0.40 100.1 ± 0.40 99.9 ± 0.39 100.0 ± 0.41 99.1 ± 0.40
t= 0.88 t= 1.78 t= 0.88 t= 1.33 t= 1.11
F= 1.14 F= 1.14 F= 1.10 F= 1.20 F= 2.32
Authentic chlorphen 99.9 ± 0.72 100.0 ± 0.70 101.1 ± 0.71 99.8 ± 0.7 100.1 ± 0.71 99.31 ± 0.33
t= 0.21 t= 0.42 t= 0.21 t= 0.42 t= 1.11
F= 1.03 F= 1.01 F= 1.01 F= 1.01 F= 2.09
Laboratory prepared mix. for phenylephrine 100.0 ± 0.65 99.9 ± 0.66 99.8 ± 0.65 99.9 ± 0.50 100.0 ± 0.73 99.4 ± 0.29
t= 0.53 t= 0.47 t= 0.55 t= 0.49 t= 0.21
F= 1.05 F= 1.35 F= 1.68 F= 1.26 F= 1.20
Laboratory prepared mix. for chlorphen 100.1 ± 0.39 99.8 ± 0.40 100.0 ± 0.38 100.2 ± 0.39 99.9 ± 0.41 98.1 ± 0.47
t= 0.83 t= 0.28 t= 0.62 t= 0.55 t= 0.24
F= 1.03 F= 1.03 F= 1.00 F= 1.00 F= 2.10
Sine Up syrup. for phenylephrine 99.6 ± 0.53 99.8 ± 0.50 99.7 ± 0.56 99.9 ± 0.55 99.8 ± 0.54 99.3 ± 0.43
t= 0.47 t= 0.24 t= 0.71 t= 0.47 t= 1.20
F= 1.06 F= 1.06 F= 1.04 F= 1.02 F= 2.10
Sine Up syrup for chlorphen 100.2 ± 0.75 100.1 ± 0.69 100.0 ± 0.75 100.0 ± 0.77 99.9 ± 0.80 99.1 ± 0.34
t= 0.24 t= 0.47 t= 0.45 t= 0.68 t= 0.21
F= 1.17 F= 1.00 F= 1.05 F= 1.14 F= 1.23
Theoretical values at 95% conﬁdence limit are t= 3.58 and F= 4.28.
20 N.H. Al-Shaalanregression equations are shown in Table 1. The LOD and LOQ
values were calculated as described in Section 3.1.
In order to demonstrate the validity and applicability of the
proposed HPLC method, recovery tests were carried out by
analyzing laboratory prepared mixtures of phenylephrine
hydrochloride and chlorpheniramine maleate, with different
ratios (Table 2).
3.5. Application to pharmaceutical dosage form
The four proposed methods are successfully applied for the
simultaneous determination of both drugs in Sine Up syrup
without interference of the excipients present and without
prior separation. The utility of the four proposed methods
was veriﬁed by replicate estimations of the pharmaceutical
preparation and results obtained were evaluated statistically
(Table 2).
3.6. Validity of the proposed methods
Statistical analysis of the results obtained for the proposed
methods (Table 2), shows that all the suggested measurements
are equally precise and accurate to the reported methods (Mof-
fat et al., 1986).
4. Conclusion
The D1 and DD1, multivariate (CLS and PCR) and HPLC
methods enable the quantitation of phenylephrine hydrochlo-
ride and chlorpheniramine maleate binary mixture with good
accuracy and precision, either in laboratory prepared samples
or in pharmaceutical dosage forms. By comparing the results
of the four proposed methods, no signiﬁcant difference is ob-
tained; HPLC method has the superiority over spectrophoto-
metric methods in analyzing the binary mixture of studieddrugs. All of the proposed procedures have the advantage of
being rapid, precise and direct. DD1 method has two advanta-
ges over the D1 method, the ﬁrst is the high sensitivity and
accuracy, the second is the easy measurements at any peak sig-
nal giving higher values.
Classical least squares and PCR multivariate calibration
analysis were developed for the analysis of the laboratory pre-
pared mixtures and pharmaceutical dosage forms. The good
recoveries obtained in all cases as well as the reliable agreement
with the reported procedures proved that, the proposed meth-
od could be applied efﬁciently for determination of phenyleph-
rine hydrochloride and chlorpheniramine maleate binary
mixture with quite satisfactory precision and could be easily
used in a quality control laboratory for their analysis. Good
resolution between the studied drugs and the chosen internal
standard was obtained in a short analysis time using simple
extraction procedure without interference of endogenous sub-
stances present in serum samples.
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